Abstract
The role of neuroactive amino acids in seizure phenomena has been a subject of intensive study in the past (Morselli et al., 1981; Perry and Hansen, 1981; Huxtable et al., 1983). An additional impetus to this area of research followed the observation that exogenous excitatory amino acids, such as kainic acid, can produce in animals an electroencephalographic and neuropathological profile reminiscent of that found in human patients with temporal lobe epilepsy (Nadler et al., 1978; Pisa et al., 1980; Lothman and Collins, 1981; Sloviter and Damiano, 1981; French et al., 1982; Ben-Ari, 1985). Thus, it was reasonable to conclude that endogenous excitatory amino acids bearing structural similarities to kainate might play pivotal roles in the etiology of seizure disorders. In this regard, glutamate, aspartate, and, more recently, quinolinate (QUIN), endogenous excitants of central nervous tissue, have been suggested as factors involved in initiating events leading to seizures (Lapin, 1978; Coutinho-Netto et al., 1981; Nitsch et al., 1983; Smialowski, 1983; Schwarcz et al., 1984). This conjecture has been indirectly validated by the recent observations that excitatory amino acid antagonists possess anticonvulsant activity in a number of animal models of epilepsy (Croucher et al., 1982; Meldrum et al., 1983; Schwarcz et al., 1984).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Barbeau, A., Inoue, N., Tsukada, Y., and Butterworth, R.F., 1975, The neuropharmacology of taurine, Life Sci., 17: 669.
Ben-Ari, Y., 1985, Limbic seizure and brain damage produced by kainic acid; mechanisms and relevance to human temporal lobe epilepsy, Neuroscience, 14: 375.
Bonhaus, D.W., and Huxtable, R.J., 1984, Seizure-susceptibility and decreased taurine transport in the genetically epileptic rat, Neurochem. Int., 6: 365.
Bonhaus, D.W., Pasantes-Morales, H., and Huxtable, R.J., 1985, Actions of guanidinoethane sulfonate on taurine concentration, retinal morphology and seizure threshold in the neonatal rat, Neurochem. Int., 7: 263.
Coutinho-Netto, J., Abdul-Ghani, A.S., Collins, J.F., and Bradford, H.F., 1981, Is glutamate a trigger factor in epileptic hyperactivity?, Epilepsia, 21: 289.
Croucher, M.J., Collins, J.F., and Meldrum, B.S., 1982, Anticonvulsant action of excitatory amino acid antagonists, Science, 216: 899.
Curtis, D.R., and Johnston, G.A.R., 1974, Amino acid transmitters in the mammalian central nervous system, Ergeb. Physiol., 69: 97.
Enna, S.J., Kondell, D.A., and Browner, M., 1981, Differential effects of y-vinyl GABA on chemically induced seizures, in: Neurotransmitters, Seizures and Epilepsy, P.L. Morselli, K.G., Lloyd, W. Löscher, B. Meldrum and E.H. Reynolds, eds., Raven Press, New York, p. 107.
Foster, A.C., Vezzani, A., French, E.D., and Schwarcz, R., 1984, Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid, Neurosci. Lett., 48: 273.
French, E.D., and Siggins, G.R., 1980, An iontophoretic survey of opioid peptide actions in the rat limbic system: in search of opiate epileptogenic mechanisms, Regulatory Peptides, 1: 127.
French, E.D., Aldinio, C., and Schwarcz, R., 1982, Intrahippocampal kainic acid, seizures and local neuronal degeneration: relationships assessed in unanesthetized rats, Neuroscience, 7: 2525.
Ganong, A.H., Lanthorn, T.H., and Cotman, C.W., 1983, Kynurenic acid inhibits synaptic and acidic amino acid-induced responses in the rat hippocampus and spinal cord, Brain Res., 273: 170.
Haug, P., and Nitsch, C., 1982, Increase in taurine content before onset of seizures induced by a glutamate decarboxylase inhibitor, Exp. Brain Res., 48: 463.
Hruska, R.E., Huxtable, R.J., and Yamamura, H.I., 1978, High-affinity, temperature sensitive, and sodium dependent transport of taurine in rat brain, in: Taurine and Neurological Disorders, A. Barbeau and R.J. Huxtable, eds., Raven Press, New York, p. 109.
Huxtable, R.J., 1981, Insights on function: metabolism and pharmacology of taurine in the brain, in: The Role of Peptides and Amino Acids as Neurotransmitters, J.B. Lombardini and A. Kenny, eds., Alan R. Liss, Inc., New York, p. 53.
Huxtable, R.J., Laird, H., Lippincott, S.E., and Walson, P., 1983, Epilepsy and the concentrations of plasma amino acids in humans, Neurochem. Int., 5: 125.
Krnjevié, K., and Puil, E., 1976, Electrophysiological studies on actions of taurine, in: Taurine, R. Huxtable and A. Barbeau, eds., Raven Press, New York, p. 179.
Kurachi, M., Yoshihara, K., and Aihara, H., 1983, Effect of taurine on depolarizations induced by L-glutamate and other excitatory amino acids in the isolated spinal cord of the frog, Jap. J. Pharmacol., 33: 1247.
Lapin, I.P., 1978, Stimulant and convulsive effects of kynurenines injected into brain ventricles in mice, J. Neural Trans., 42: 37.
Lehmann, A., Hagberg, H., and Hamberger, A., 1984, A role for taurine in the maintenance of homeostasis in the central nervous system during hyperexcitation?, Neurosci. Lett., 52: 341.
Lehmann, A., Lazarewicz, J.W., and Zeise, M., 1985, N-methylaspartate-evoked liberation of taurine and phosphoethanolamine in vivo: site of release, J. Neurochem., 45: 1172.
Lerma, J., Herreras, O., Herranz, A.S., Munoz, D., and del Rio, R.M., 1984, In vivo effects of nipecotic acid on levels of extracellular GABA and taurine, and hippocampal excitability, Neuropharmacology, 23: 595.
Lombardini, J.B., 1978, High-affinity transport of taurine in the mammalian central nervous system, in: Taurine and Neurological Disorders, A. Barbeau and R. Huxtable, eds., Raven Press, New York, p. 119.
Lothman, E.W., and Collins, R.C., 1981, Kainic acid-induced limbic seizures: metabolic, behavioral, electroencephalographic and neuropathological correlates, Brain Res., 218: 299.
McBride, W.J., and Frederickson, R.C.A., 1978, Neurochemical and neurophysio- logical evidence for a role of taurine as an inhibitory neurotransmitter in the cerebellum of the rat, in: Taurine and Neurological Disorders, A. Barbeau and R.J. Huxtable, eds., Raven Press, New York, p. 415.
Meldrum, B.S., Croucher, M.J., Badman, G., and Collins, J.F., 1983, Antiepileptic action of excitatory amino acid antagonists in the photosensitive baboon, Papio papio, Neurosci. Lett., 39: 101.
Moroni, F., Lombardini, G., Carla, V., and Moneti, G., 1984, The excitotoxin quinolinic acid is present and unevenly distributed in the rat brain, Brain Res., 295: 352.
Morselli, P.L., Lloyd, K.G., Löscher, W., Meldrum, B., and Reynolds, E.H., 1981, Neurotransmitters, Seizures and Epilepsy, Raven Press, New York.
Mutani, R., Bergamini, L., Delsedine, M., and Durelli, L., 1974, Effects of taurine in chronic experimental epilepsy, Brain Res., 79: 330.
Nadler, J., Perry, B.W., and Cotman, C.W., 1978, Intraventricular kainic acid preferentially destroys hippocampal pyramidal cells, Nature, 271: 676.
Nitsch, C., Schmude, B., and Haug, P., 1983, Alterations in the content of amino acid neurotransmitters before the onset and during the course of methoxypyridoxine-induced seizures in individual rabbit brain regions, J. Neurochem., 40: 1571.
Oja, S.S., and Kontro, P., 1978, Neurotransmitter actions of taurine in the central nervous system, in: Taurine and Neurological Disorders, A. Barbeau and R.J. Huxtable, eds., Raven Press, New York, p. 181.
Olney, J.W., 1983, Excitotoxins: an overview, in: Excitotoxins, K. Fuxe,P. Roberts and R. Schwarcz, eds., Macmillan, London, p. 82.
Perkins, M.N. and Stone, T.W., 1983, The pharmacology and regional varia-tions of quinolinic acid evoked excitations in the rat CNS, J. Pharmacol.Exp. Ther., 226:551.
Perry, T.L., and Hansen, S., 1981, Amino acid abnormalities in epileptogenic foci, Neurology, 31: 872.
Phillis, J.W., 1978, Overview of neurochemical and neurophysiological actions of taurine, in: Taurine and Neurological Disorders, A. Barbeau and R.J. Huxtable, eds., Raven Press, New York, p. 289.
Pisa, M., Sanberg, P.R.,Corcoran, M.E., and Fibiger, H.C., 1980, Spontaneously recurrent seizures after intracerebral injections of kainic acid in rat: a possible model of human temporal lobe epilepsy, Brain Res., 200: 481.
Ribak, C.E., Harris, A.B., Vaughan, J.E., and Roberts, E., 1979, Inhibitory GABAergic terminals decrease at sites of focal epilepsy, Science, 205: 211.
Schmid, R., Sieghart, W., and Karobath, M., 1975, Taurine uptake in synaptosomal fractions of rat cerebral cortex, J. Neurochem., 25: 5.
Schwarcz, R., and Köhler, C., 1983, Differential vulnerability of central neurons of the rat to quinolinic acid, Neurosci. Lett., 38: 85.
Schwarcz, R., Whetsell, W.O. Jr., and Mangano, R.M., 1983, Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain, Science, 219: 316.
Schwarcz, R., Brush, G.S., Foster, A.C., and French, E.D., 1984, Seizure activity and lesions after intrahippocampal quinolinic acid injection, Exp. Neurol., 84: 1.
Sloviter, R.S., and Damiano, B.P., 1981, On the relationship between kainic acid-induced epileptiform activity and hippocampal neuronal damage, Neuropharmacologv, 20: 1003.
Smialowski, A., 1983, Excitatory effect of intrahippocampal injection of glutamic acid on rabbit EEG, J. Neural Trans., 58: 205.
Toth, E., Lajtha, A., Sarhan, S., and Seiler, N., 1983,. Anticonvulsant effects of some inhibitory neurotransmitter amino acids, Neurochem. Res., 8: 291.
Ungerstedt, U., Herrera-Marschitz, M., Jungnelius, U., Stahle, L., Tossman, U., and Zetterström, T., 1982, Dopamine synaptic mechanisms reflected in studies combining behavioral recordings and brain dialysis, Adv. Dopamine Res., 37: 219.
Van Gelder, N.M., 1972, Antagonism by taurine of cobalt induced epilepsy in cat and mouse, Brain Res., 47: 157.
Van Gelder, N.M., and Courtois, A., 1972, Close correlation between changing content of specific amino acids in epileptogenic cortex of cats and severity of epilepsy, Brain Res., 43: 477.
Van Gelder, N.M., 1983, A central mechanism of action for taurine, Neurochem. Res., 8: 687.
Vezzani, A., Ungerstedt, U., French, E.D., and Schwarcz, R., 1985, In vivo brain dialysis of amino acids and simulataneous EEG measurements following intrahippocampal quinolinic acid injection: evidence fora dissociation between neurochemical changes and seizures, J. Neurochem., 45: 335.
Wheler, G.H.T., Osborne, R.H., Bradford, H.F., and Davison, A.N., 1977, Uptake studies of taurine in vivo and its effects on the course of experimental focal epilepsy in rats, Brain Res., 136: 535.
Whetsell, W.O. Jr., and Schwarcz, R., 1983, Mechanisms of excitotoxins examined in organotypic cultures of rat central nervous system, in: Excitotoxins, K. Fuxe, P. Roberts, and R. Schwarcz, eds., Macmillan, London, p. 207.
Wolfensberger, M., Amsler, U., Cuénod, M., Foster, A.C., Whetsell, W.O. Jr., and Schwarcz, R., 1983, Identification of quinolinic acid in rat and human brain tissue, Neurosci. Lett., 41:247.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Plenum Press, New York
About this chapter
Cite this chapter
French, E.D., Vezzani, A., Whetsell, W.O., Schwarcz, R. (1986). Anti-Excitotoxic Actions of Taurine in the Rat Hippocampus Studied in Vivo and in Vitro . In: Schwarcz, R., Ben-Ari, Y. (eds) Excitatory Amino Acids and Epilepsy. Advances in Experimental Medicine and Biology, vol 203. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-7971-3_26
Download citation
DOI: https://doi.org/10.1007/978-1-4684-7971-3_26
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-7973-7
Online ISBN: 978-1-4684-7971-3
eBook Packages: Springer Book Archive